<DOC>
	<DOC>NCT01046162</DOC>
	<brief_summary>The purpose of this study is to compare bioavailability between formulations of alprazolam in tablets to determine their bioequivalence in terms of rate and magnitude of absorption.</brief_summary>
	<brief_title>A Study Of Two Oral Preparations Of 2 Mg Alprazolam In Healthy Volunteers Under Fasting Conditions</brief_title>
	<detailed_description />
	<mesh_term>Alprazolam</mesh_term>
	<criteria>Healthy volunteers (male or female) Age between 1840 years body mass index (QueteletÂ´s index) between 1827 Unhealthy subjects Volunteers who require any medication over the course of the study Volunteers who have received investigational drugs within 60 days prior to the study</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>40 Years</maximum_age>
	<verification_date>August 2010</verification_date>
	<keyword>Alprazolam</keyword>
	<keyword>Tafil</keyword>
	<keyword>Xanax</keyword>
	<keyword>Bioequivalence</keyword>
	<keyword>Drug Kinetics</keyword>
</DOC>